| abstract |
The present invention relates to N-hydroxyamine derivatives of Formula (I) and the use thereof in particular for the treatment and / or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis. , including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis. |